Nation
NAFDAC Pledges Repositioning Nigeria To Manufacture Vaccines
The Director-General, National Agency for Food, Drug Administration and Control (NAFDAC), Prof. Mojisola Adeyeye, has pledged to make Nigeria a vaccine manufacturing hub.
Adeyeye also vowed to eradicate fake and counterfeit medicine by addressing glitches in the country’s medicine supply chain.
Addressing a Press Conference to mark her reappointment for a second tenure in Abuja, Wednesday, Adeyeye said as part of her strategic goals for 2023-2028 the agency would pursue the attainment of the World Health Organisation (WHO) Vaccine Lot Release ML4 to position Nigeria strategically for vaccine manufacturing.
Apart from ensuring good manufacturing practice of the Nigeria vaccine company, Adeyeye said NAFDAC would strive to attain the World Listed Authority (WLA) status that would enable global trade of Nigerian-made pharmaceuticals through collaborative registration with other regulatory agencies.
“We will seek to attain WHO ML4 and WLA status. Attainment will enable global trade of Nigerian-made pharmaceuticals through collaborative registration with other regulatory agencies.
“Local Pharma manufacturers to be more competitive in AfCFTA, attain Vaccine Lot Release ML4 to position Nigeria strategically for vaccine manufacturing and ensure good manufacturing practice of Nigeria vaccine company.
“We will essure quality, safety and efficacy of vaccines manufactured in Nigeria or imported,” she said.
The DG also pledged that NAFDAC would establish vaccine Clinical Trial Research and service pipeline for the local manufacturer while pursuing newer initiatives to boost the fortunes of the country’s drug manufacturing industry.
Adeyeye, who expressed worry over the persistence of counterfeit medicine in the Nigerian market, assured that the agency would in her second tenure pursue newer initiatives to monitor and sanitise the drug supply chain.
According to her, continual sanitisation of the supply chain units would mitigate counterfeits and fake products.
She further assured that NAFDAC would scale up the track and trace of imported and locally manufactured pharmaceuticals and establish structured and active tracking and tracing through solution providers.
To this end, the DG said the agency would initiate track and trace of foods to ensure that they are safe for consumption.
She also said the agency would mount continuous vigilance in order to reduce distribution of counterfeit medicines, and narcotics in the country
The NAFDAC boss also revealed other new interventions being planned by the agency including training of staff on Active Pharmaceutical Ingredients (API) regulation, developing NAFDAC-Industry API Manufacturing Regulation and enhance Research and Development Training Platforms with the Pharmaceutical Industry in the country.
Speaking on research and development, Adeyeye said NAFDAC would iIncrease collaboration with the academia on regulatory science training
In addition, she pledged continuous strengthening of regulatory activities and creative engagement of Micro, Small and Medium Enterprises (MSMEs).
Nation
REAN, SON synergise to curb fake renewable energy product
Nation
Self Help Africa programme expands water access for 320,000 Nigerians
Nation
Lagos Residents Stranded As Floods Cut Off Ajah, Mafoluku Communities
-
Rivers3 days ago
Rivers Police Uncovers Firearm Concealed In Loaf Of Bread
-
Niger Delta3 days agoPro-Chancellor Hands Over Okey Onuchuku Peace, Conflict Institute Building
-
Sports3 days ago
Six Nigerians To Play For NBA Teams
-
Business3 days agoIPMAN Raises Concern Over Delay In Chinese Refinery Deal …Predicts Lower Fuel Prices Through Competition
-
News3 days agoFubara Reaffirms Commitment To Blue Economy, Private Sector Growth …Calls For Protection Of Marine Resources
-
Business3 days ago
Gas Economy: Decade of Gas, Pi-CNG/ EV Deepen Media Engagement
-
Politics3 days agoSenate Defends Passage Of State Police Bill
-
Business3 days ago
Navy Hands Over Five Suspected Stowaways to NIS
